1. Home
  2. BTBT vs FHTX Comparison

BTBT vs FHTX Comparison

Compare BTBT & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTBT
  • FHTX
  • Stock Information
  • Founded
  • BTBT 2015
  • FHTX 2015
  • Country
  • BTBT United States
  • FHTX United States
  • Employees
  • BTBT N/A
  • FHTX N/A
  • Industry
  • BTBT Finance: Consumer Services
  • FHTX Medicinal Chemicals and Botanical Products
  • Sector
  • BTBT Finance
  • FHTX Health Care
  • Exchange
  • BTBT Nasdaq
  • FHTX Nasdaq
  • Market Cap
  • BTBT 304.9M
  • FHTX 310.9M
  • IPO Year
  • BTBT 2018
  • FHTX 2020
  • Fundamental
  • Price
  • BTBT $3.89
  • FHTX $5.90
  • Analyst Decision
  • BTBT Strong Buy
  • FHTX Buy
  • Analyst Count
  • BTBT 2
  • FHTX 3
  • Target Price
  • BTBT $6.00
  • FHTX $13.00
  • AVG Volume (30 Days)
  • BTBT 15.2M
  • FHTX 143.7K
  • Earning Date
  • BTBT 08-13-2024
  • FHTX 08-02-2024
  • Dividend Yield
  • BTBT N/A
  • FHTX N/A
  • EPS Growth
  • BTBT N/A
  • FHTX N/A
  • EPS
  • BTBT 0.30
  • FHTX N/A
  • Revenue
  • BTBT $66,938,222.00
  • FHTX $33,896,000.00
  • Revenue This Year
  • BTBT $194.33
  • FHTX N/A
  • Revenue Next Year
  • BTBT $40.14
  • FHTX $8.63
  • P/E Ratio
  • BTBT $12.97
  • FHTX N/A
  • Revenue Growth
  • BTBT 109.26
  • FHTX 64.41
  • 52 Week Low
  • BTBT $1.76
  • FHTX $2.70
  • 52 Week High
  • BTBT $5.27
  • FHTX $9.97
  • Technical
  • Relative Strength Index (RSI)
  • BTBT 59.40
  • FHTX 51.91
  • Support Level
  • BTBT $3.63
  • FHTX $5.62
  • Resistance Level
  • BTBT $4.37
  • FHTX $6.98
  • Average True Range (ATR)
  • BTBT 0.33
  • FHTX 0.58
  • MACD
  • BTBT 0.02
  • FHTX 0.09
  • Stochastic Oscillator
  • BTBT 65.17
  • FHTX 51.13

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries.. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. It generates revenue from digital asset mining and ETH staking business.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: